BIOCYTOGEN Overview
Company Headquarters: Massachusetts, US
Founded: 2009
Workforce: ~1,300
Company Working: BIOCYTOGEN is a biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. It offers immunoglobulins, monoclonal antibodies, recombinant humanized antibodies, and others. It also provides drug development, therapeutic antibody discovery and development, and other services. The company serves over 2,200 clients all over the world. It operates in Haimen Jiangsu, Shanghai, Boston, USA, and Heidelberg, Germany.
Strategy
BIOCYTOGEN The main goal is to advance life sciences by using superior, customized models to test the limits of target models that have been humanized for use in biomedical research. The company intends to create technological platforms that will hasten the development of new drugs. Additionally, it aims to empower researchers by providing the necessary information to break down research obstacles. It also strives to be a global leader in providing seamless preclinical services to its clients
